ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) price-to-sales (or "P/S") ratio of 3.8x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around ...
Source LinkACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) price-to-sales (or "P/S") ratio of 3.8x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around ...
Source Link
Comments